Gurunavi, Inc. (TYO:2440)

Theseus Pharmaceuticals Revenue

Gurunavi had revenue of 3.08B JPY in the quarter ending June 30, 2025, with 7.00% growth. This brings the company's revenue in the last twelve months to 13.66B, up 2.90% year-over-year. In the fiscal year ending March 31, 2025, Gurunavi had annual revenue of 13.46B with 3.67% growth.

• Revenue (ttm): 13.66B
• Revenue Growth: +2.90%
• P/S Ratio: 1.02
• Revenue / Employee: 18.24M
• Employees: 749
• Market Cap: 13.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	13.46B	476.00M	3.67%
Mar 31, 2024	12.98B	686.00M	5.58%
Mar 31, 2023	12.30B	-556.00M	-4.33%
Mar 31, 2022	12.85B	-3.33B	-20.57%
Mar 31, 2021	16.18B	-14.75B	-47.68%